AGRX

Agile Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

AGRX price

Agile Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AGRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals AGRX

Valuation

P/E

0.00

Sector -2.23

Industry -6.43

P/BV

0.00

Sector 2.14

Industry 1.86

P/Revenue (PSR)

Sector 1.98

Industry 3.13

EV/EBITDA

Sector -24.41

Industry -31.34

EV/EBIT

Sector -37.37

Industry -46.59

P/EBITDA

Sector -0.01

Industry -2.95

P/EBIT

Sector -2.00

Industry -5.83

P/Total Assets

Sector 1.15

Industry 1.22

P/Ativo Circ. Liq.

Sector -10.54

Industry -7.84

P/Cap.Giro

Sector 0.02

Industry 0.99

EPS

-2.27

Sector -0.94

Industry -1.44

BVPS

-3.13

Sector 3.93

Industry 2.20

Efficiency

Gross Margin

63.62%

Sector 44.21%

Industry 46.60%

EBITDA Margin

-210.93%

Sector -312.85%

Industry -17,123,075.56%

EBIT Margin

-212.72%

Sector -193.57%

Industry -17,075,545.37%

Operating Margin

-62.86%

Sector -25.72%

Industry -34.57%

Net Profit Margins

-73.51%

Sector -30.17%

Industry -37.93%

Giro Ativos

0.37

Sector 0.12

Industry 0.05

Profitability

ROE

72.38%

Sector -35.35%

Industry -48.50%

ROA

-106.00%

Sector -29.04%

Industry -52.44%

ROIC

-598.26%

Sector -439.00%

Industry -520.61%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.55

Sector 1.87

Industry 2.33

Dívida Líquida/EBITDA

0.00

Sector -1.64

Industry -1.99

Dívida Líquida/EBIT

0.00

Sector -0.81

Industry -1.80

Dívida Líquida/Patrimônio

0.00

Sector -0.35

Industry -0.87

Dívida Bruta/Patrimônio

0.00

Sector 0.17

Industry -0.18

Equity/Assets

-1.46

Sector 0.42

Industry 0.47

Liabilities/Assets

-1.46

Sector 0.46

Industry 0.41

Growth

5Y Revenue CAGR

39.38%

Sector -

Industry -

5Y Earnings CAGR

-26.69%

Sector -

Industry -

Fundamentals AGRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AGRX	0.00	0.00	72.38%	0.00%	$-	-73.51%
LLY	42.55	34.48	81.02%	0.54%	$1.08 T	34.99%
ISRG	38.26	6.56	17.15%	0.00%	$120.09 B	28.45%
SNY	7.10	1.26	17.79%	4.07%	$105.96 B	14.75%
NVS	23.21	7.06	30.41%	2.00%	$296.12 B	22.50%
TMO	29.78	3.93	13.19%	0.32%	$207.50 B	15.04%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.51 B	13.20%
GSK	13.15	4.44	33.77%	3.42%	$103.21 B	17.79%
CVS	46.73	1.76	3.78%	2.47%	$137.02 B	0.72%
BSX	18.64	2.57	13.78%	0.00%	$66.45 B	17.29%
TMDX	13.95	4.86	34.80%	0.00%	$2.40 B	27.04%
IDXX	39.73	27.96	70.38%	0.00%	$43.51 B	24.63%
RMD	18.74	4.39	23.41%	1.22%	$28.48 B	27.44%
HCA	12.70	-28.97	-228.14%	0.78%	$86.27 B	8.89%
DHR	33.74	2.57	7.61%	0.54%	$135.09 B	15.95%
SYK	37.64	5.47	14.52%	1.05%	$125.61 B	13.21%
PHG	22.19	1.90	8.56%	3.85%	$25.07 B	5.50%
COHR	117.65	5.01	4.26%	0.00%	$55.16 B	7.10%
INMD	11.06	1.46	13.18%	0.00%	$963.90 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AGRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Agile Therapeutics

Agile Therapeutics Inc.

Average Investor10 user rating

4.0 (4 people)

United States

29 years

Founded: 1997

2014

Time since IPO - 12 years

28

Employees

Agile Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-21.91 million.

The company employs approximately 28 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Agile Therapeutics Inc. reported $21.57 million in revenue, generating net income of $-15.86 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AGRX.

Market cap

Net worth

$-21.91 million

$-21,910,000.00

Assets

$14.96 million

$14,960,000.00

Total Shares Outstanding

7.00 million

7,000,000

Average Daily Trading Volume

Sector

Health

Industry

Pharmaceutical Products

AGRX

AGRX revenue and profits

Financial Results AGRX

DRAG THE FRAME TO SEE MORE DATA

AGRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$107.07 87,21% (12M)

P/E

46.73

2.47%

ROE

3.78%

P/BV

1.76

CI - Cigna

$291.02 2,28% (12M)

P/E

11.72

2.13%

ROE

15.39%

P/BV

1.80

CNC - Centene

$64.08 138,57% (12M)

P/E

-4.85

0.00%

ROE

-29.93%

P/BV

1.45

HUM - Humana

$381.15 67,01% (12M)

P/E

41.90

0.67%

ROE

6.06%

P/BV

2.54

SNY - Sanofi

$44.00 --7,57% (12M)

P/E

7.10

4.07%

ROE

17.79%

P/BV

1.26

LLY - Eli Lilly

$1,197.53 58,30% (12M)

P/E

42.55

0.54%

ROE

81.02%

P/BV

34.48

HCA - HCA Healthcare

$389.62 15,17% (12M)

P/E

12.70

0.78%

ROE

-228.14%

P/BV

-28.97

NVS - Novartis

$156.11 36,98% (12M)

P/E

23.21

2.00%

ROE

30.41%

P/BV

7.06